Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Walle, A. Raes, D. Castillo, N. Lutz-Dettinger, A. Dejaegher (1997)
Advantages of HCO3 solution with low sodium concentration over standard lactate solutions for acute peritoneal dialysis.Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 13
M. Wolfson, B. Piraino, R. Hamburger, A. Morton (2002)
A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.American journal of kidney diseases : the official journal of the National Kidney Foundation, 40 5
M. Nakayama, K. Yokoyama, H. Kubo, H. Matsumoto, T. Hasegawa, T. Shigematsu, Y. Kawaguchi, O. Sakai (1996)
The effect of ultra-low sodium dialysate in CAPD. A kinetic and clinical analysis.Clinical nephrology, 45 3
P. Margetts, S. Gyorffy, M. Kolb, Lisa Yu, C. Hoff, C. Holmes, J. Gauldie (2002)
Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats.Journal of the American Society of Nephrology : JASN, 13 3
C. Fijter, H. Verbrugh, L. Oe, Edith Peters, J. Meulen, A. Donker, J. Verhoef (1992)
Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.Kidney international, 42 4
Cristina Lage, M. Pischetsrieder, C. Aufricht, A. Jörres, H. Schilling, J. Passlick–Deetjen (2000)
First In Vitro and In Vivo Experiences with Stay·Safe Balance, A pH-Neutral Solution in a Dual-Chambered BagPeritoneal Dialysis International, 20
J. Witowski, A. Jörres, K. Korybalska, K. Książek, J. Wiśniewska-Elnur, T. Bender, J. Passlick–Deetjen, A. Bręborowicz (2003)
Glucose degradation products in peritoneal dialysis fluids: do they harm?Kidney international. Supplement, 84
A. Tauer, T. Knerr, T. Niwa, T. Schaub, Cristina Lage, J. Passlick–Deetjen, M. Pischetsrieder (2001)
In vitro formation of N(epsilon)-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis.Biochemical and biophysical research communications, 280 5
J. Plum, Stella Gentile, C. Verger, R. Brunkhorst, U. Bahner, B. Faller, J. Peeters, P. Freida, D. Struijk, R. Krediet, B. Grabensee, A. Tranaeus, J. Filho (2002)
Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.American journal of kidney diseases : the official journal of the National Kidney Foundation, 39 4
M. Park, Hyon Lee, Won Chu, Dong Yang, S. Hwang (2000)
Peritoneal Accumulation of Age and Peritoneal Membrane PermeabilityPeritoneal Dialysis International, 20
Maria Stoenoiu, Jie Ni, C. Verkaeren, H. Debaix, Jean-Christophe Jonas, Norbert Lameire, J. Verbavatz, Olivier Devuyst (2003)
Corticosteroids induce expression of aquaporin-1 and increase transcellular water transport in rat peritoneum.Journal of the American Society of Nephrology : JASN, 14 3
C. Mistry, R. Gokal (1993)
Can ultrafiltration occur with a hypo-osmolar solution in peritoneal dialysis?: The role for 'colloid' osmosis.Clinical science, 85 4
R. Montagnac, A. Slingeneyer, F. Schillinger (2001)
Aseptic peritonitis: role of icodextrin.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 16 2
G. Enia, A. Mandalari, Giuseppina Ventura, D. Pustorino, V. Panuccio (2003)
Sterile icodextrin-associated peritonitis may induce hypersensitivity and recurrent peritonitis on re-challenge.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 18 3
M. Pannekeet, B. Atasever, D. Struijk, R. Krediet (1997)
Analysis of Ultrafiltration Failure in Peritoneal Dialysis Patients by Means of Standard Peritoneal Permeability AnalysisPeritoneal Dialysis International, 17
R. Foley, P. Parfrey, P. Parfrey, J. Harnett, J. Harnett, G. Kent, G. Kent, Christopher Martin, Christopher Martin, D. Murray, D. Murray, P. Barré, P. Barré (1995)
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.Kidney international, 47 1
A. Tzamaloukas, Saddler Mc, G. Murata, D. Malhotra, P. Sena, D. Simon, K. Hawkins, K. Morgan, M. Nevárez, B. Wood (1995)
Symptomatic fluid retention in patients on continuous peritoneal dialysis.Journal of the American Society of Nephrology : JASN, 6 2
O. Devuyst, N. Topley, John Williams (2002)
Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 17 Suppl 3
Kjeld Otte, Maria Gonzalez, M. Bajo, G. Peso, J. Heaf, G. Erauzkin, J. Tomero, H. Dieperink, J. Povlsen, A. Hopwood, J. Filho, D. Faict (2003)
Clinical Experience with a New Bicarbonate (25 Mmol/L)/Lactate (10 Mmol/L) Peritoneal Dialysis SolutionPeritoneal Dialysis International, 23
(2000)
For - mation of the glucose degradation product 3 - deoxyglucosone and other carbonyl compounds in single - or double - chamber peritoneal dialysis fluids ( abstract )
T. Liberek, N. Topley, C. Mistry, G. Coles, Tracy Morgan, Rosalie Quirk, John Williams (1993)
Cell Function and Viability in Glucose Polymer Peritoneal Dialysis FluidsPeritoneal Dialysis International, 13
A. Fusshöller, B. Grabensee, J. Plum (2003)
Effluent CA 125 Concentration in Chronic Peritoneal Dialysis Patients: Influence of PD Duration, Peritoneal Transport and PD RegimenKidney and Blood Pressure Research, 26
S. Mujais, K. Nolph, R. Gokal, P. Blake, J. Burkart, G. Coles, Y. Kawaguchi, H. Kawanishi, S. Korbet, R. Krediet, B. Lindholm, D. Oreopoulos, B. Rippe, R. Selgas (2000)
Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 20 Suppl 4
A. Fusshöller, Sandra Nieden, B. Grabensee, J. Plum (2002)
Peritoneal fluid and solute transport: influence of treatment time, peritoneal dialysis modality, and peritonitis incidence.Journal of the American Society of Nephrology : JASN, 13 4
S. Davies, G. Woodrow, K. Donovan, J. Plum, P. Williams, A. Johansson, H. Bosselmann, O. Heimbürger, O. Simonsen, A. Davenport, A. Tranaeus, J. Filho (2003)
Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial.Journal of the American Society of Nephrology : JASN, 14 9
A. Vriese, S. Mortier, N. Lameire (2001)
Glucotoxicity of the peritoneal membrane: the case for VEGF.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 16 12
(2002)
Morphological changes in the peritoneal membrane of patients on peritoneal dialysis correlate with total glucose exposure and with peritonitis rates (abstract)
P. Heering, M. Brause, J. Plum, B. Grabensee (2001)
Peritoneal Reaction to Icodextrin in a Female Patient on CAPDPeritoneal Dialysis International, 21
M. Wilkie, Mandy Plant, L. Edwards, C. Brown (1997)
Icodextrin 7.5% Dialysate Solution (Glucose Polymer) in Patients with Ultrafiltration Failure: Extension of Capd Technique SurvivalPeritoneal Dialysis International, 17
K. Wieczorowska-Tobis, A. Połubińska, T. Schaub, H. Schilling, J. Wiśniewska, J. Witowski, J. Passlick–Deetjen, A. Bręborowicz (2001)
Influence of Neutral-Ph Dialysis Solutions on the Peritoneal Membrane: A Long-Term Investigation in RatsPeritoneal Dialysis International, 21
Suzanne Jones, C. Holmes, R. Krediet, R. Mackenzie, D. Faict, A. Tranaeus, JohnD. Williams, G. Coles, N. Topley (2001)
Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels.Kidney international, 59 4
M. Wolfson, F. Ogrinc, S. Mujais (2002)
Review of clinical trial experience with icodextrin.Kidney international. Supplement, 81
O. Heimbürger, J. Waniewski, Andrzej Warynski, A. Tranaeus, B. Lindholm (1990)
Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity.Kidney international, 38 3
A. Duwe, S. Vas, J. Weatherhead (1981)
Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitroInfection and Immunity, 33
D. Struijk, C. Douma (1998)
Future Research in Peritoneal Dialysis FluidsSeminars in Dialysis, 11
John Williams, K. Craig, N. Topley, C. Ruhland, M. Fallon, G. Newman, R. Mackenzie, Geraint Williams (2002)
Morphologic changes in the peritoneal membrane of patients with renal disease.Journal of the American Society of Nephrology : JASN, 13 2
A. Vriese, S. Mortier, N. Lameire (2001)
Neoangiogenesis in the peritoneal membrane: does it play a role in ultrafiltration failure?Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 16 11
R. Selgas, Maria-Jose Fernadez-Reyes, Eduardo Bosque, M. Bajo, Francisco Borrego, Carlos Jiménez, G. Peso, Fernando Alvaro (1994)
Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study.American journal of kidney diseases : the official journal of the National Kidney Foundation, 23 1
(1998)
Impact of a low sodium dialysate on usual parameters of cardiovascular outcome of anuric patients during APD (abstract)
A randomized prospective clinical trial with a 0 . 6 % aminoacid / 1 . 4 % glycerol peritoneal dialysis solution
A. Gũnal, S. Duman, M. Ozkahya, H. Toz, G. Aşcı, F. Akçiçek, A. Basci (2001)
Strict volume control normalizes hypertension in peritoneal dialysis patients.American journal of kidney diseases : the official journal of the National Kidney Foundation, 37 3
W. Reichel, B. Schulze, J. Dietze, W. Mende (2001)
A Case of Sterile Peritonitis Associated with Icodextrin SolutionPeritoneal Dialysis International, 21
O. Devuyst (2003)
Molecular mechanisms involved in the peritoneal membrane exposed to peritoneal dialysis.Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 23 Suppl 3
A. Jörres (2003)
Glucose Degradation Products in Peritoneal Dialysis: From Bench to BedsideKidney and Blood Pressure Research, 26
Joanne Bargman (2021)
Peritoneal dialysisPediatric Nephrology On-The-Go
S. Mujais, K. Nolph, R. Gokal, P. Blake, J. Burkart, G. Coles, Y. Kawaguchi, H. Kawanishi, S. Korbet, R. Krediet, B. Lindholm, D. Oreopoulos, B. Rippe, R. Selgas (2000)
Evaluation and Management of Ultrafiltration Problems in Peritoneal DialysisPeritoneal Dialysis International, 20
J. Witowski, J. Wiśniewska, K. Korybalska, T. Bender, A. Bręborowicz, G. Gahl, U. Frei, J. Passlick–Deetjen, A. Jörres (2001)
Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells.Journal of the American Society of Nephrology : JASN, 12 11
B. Rippe, B. Rosengren, D. Venturoli (2001)
The Peritoneal Microcirculation in Peritoneal DialysisMicrocirculation, 8
J. Passlick–Deetjen, Cristina Lage (2000)
Lactate-Buffered and Bicarbonate-Buffered Solutions with Less Glucose Degradation Products in a Two-Chamber SystemPeritoneal Dialysis International, 20
A. Vriese, S. Mortier, N. Lameire (2001)
What Happens to the Peritoneal Membrane in Long-Term Peritoneal Dialysis?Peritoneal Dialysis International, 21
A. Wieslander, A. Andrén, E. Martinson, P. Kjellstrand, M. Hultqvist (1993)
Toxicity of effluent peritoneal dialysis fluid.Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 9
J. Passlick–Deetjen, M. Pischetsrieder, J. Witowski, T. Bender, A. Jörres, Cristina Lage (2001)
In Vitro Superiority of Dual-Chambered Peritoneal Dialysis Solution with Possible Clinical BenefitsPeritoneal Dialysis International, 21
Roberto Cocchi, E. Esposti, A. Fabbri, A. Lucatello, A. Sturani, Francesco Quarello, Roberto Boero, Massimo Bruno, Claudro Dadone, Antonio Favazza, Renzo Scanziani, Adalberto Tommasi, A. Giangrande (1999)
Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 14 6
J. Heaf (1995)
CAPD adequacy and dialysis morbidity: detrimental effect of a high peritoneal equilibration rate.Renal failure, 17 5
É. Goffin, M. Tintillier, J. Cosyns, O. Devuyst (2002)
Sterile Chemical Peritonitis Secondary to Icodextrin: Immunohistopathological DescriptionPeritoneal Dialysis International, 22
Sophie Combet, MARIE-LAURE Ferrier, Mieke Landschoot, Maria Stoenoiu, Pierre Moulin, Toshio Miyata, Norbert Lameire, Olivier Devuyst (2001)
Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum.Journal of the American Society of Nephrology : JASN, 12 10
M. Zeier, V. Schwenger, R. Deppisch, U. Haug, K. Weigel, Udo Bahner, C. Wanner, H. Schneider, T. Henle, E. Ritz (2003)
Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?Kidney international, 63 1
R. Macginley, K. Cooney, Geraldine Alexander, S. Cohen, D. Goldsmith (2002)
Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution.American journal of kidney diseases : the official journal of the National Kidney Foundation, 40 5
A. Jörres, G. Gahl, N. Topley, A. Neubauer, K. Ludat, C. Müller, J. Passlick–Deetjen (1994)
In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 9 7
É. Goffin, Sophie Combet, F. Jamar, J. Cosyns, O. Devuyst (1999)
Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport.American journal of kidney diseases : the official journal of the National Kidney Foundation, 33 2
S. Mortier, A. Vriese, N. Lameire (2003)
Recent Concepts in the Molecular Biology of the Peritoneal Membrane – Implications for More Biocompatible Dialysis SolutionsBlood Purification, 21
S. Mortier, A. Vriese, J. Voorde, T. Schaub, J. Passlick–Deetjen, N. Lameire (2002)
Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products.Journal of the American Society of Nephrology : JASN, 13 2
A. Jörres, G. Gahl, U. Frei (1994)
Peritoneal dialysis fluid biocompatibility: does it really matter?Kidney international. Supplement, 48
S. Mortier, A. Vriese, R. McLoughlin, N. Topley, T. Schaub, J. Passlick–Deetjen, N. Lameire (2003)
Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane.Journal of the American Society of Nephrology : JASN, 14 5
J. Plum, G. Schoenicke, W. Kleophas, W. Kulas, F. Steffens, A. Azem, B. Grabensee (2001)
Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 16 12
É. Goffin, J. Scheiff (2002)
Transient Sterile Chemical Peritonitis in a CAPD Patient Using IcodextrinPeritoneal Dialysis International, 22
D. Churchill, Thorpe Ke, K. Nolph, P. Keshaviah, D. Oreopoulos, D. Pagé (1998)
Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group.Journal of the American Society of Nephrology : JASN, 9 7
A. Wieslander, Marika Nordin, Per Kjellstrand, Ulf Boberg (1991)
Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929.Kidney international, 40 1
C. Schmitt, B. Haraldsson, R. Doetschmann, M. Zimmering, C. Greiner, M. Böswald, G. Klaus, J. Passlick–Deetjen, F. Schaefer (2002)
Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.Kidney international, 61 4
R. Mactier, R. Khanna, Z. Twardowski, K. Nolph (1987)
Ultrafiltration failure in continuous ambulatory peritoneal dialysis due to excessive peritoneal cavity lymphatic absorption.American journal of kidney diseases : the official journal of the National Kidney Foundation, 10 6
Robert Mactier, Timothy Sprosen, Ram Gokal, Paul Williams, Marianne Lindbergh, Ramesh Naik, Ulf Wrege, Knut-Christian Gröntoft, Rutger Larsson, Jonas Berglund, Anders Tranaeus, Dirk Faict (1998)
Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain.Kidney international, 53 4
O. Heimbürger, Tao Wang, B. Lindholm (1999)
Alterations in Water and Solute Transport with Time on Peritoneal DialysisPeritoneal Dialysis International, 19
C. Fijter, C. Fijter, H. Verbrugh, H. Verbrugh, Liem Oe, Liem Oe, Erik Heezius, Erik Heezius, Ab Donker, Ab Donker, Jan Verhoef, Jan Verhoef, Ram Gokal, Ram Gokal (1993)
Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid.American journal of kidney diseases : the official journal of the National Kidney Foundation, 21 4
(2002)
Use of pH-neutral, bicarbonate buffered PD fluids in children on APD: Results of a randomized crossover trial (abstract)
O. Ortega, P. Gallar, A. Carreño, M. Gutiérrez, I. Rodríguez, A. Oliet, A. Vigil, E. Gimenez (2001)
Peritoneal Sodium Mass Removal in Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis: Influence on Blood Pressure ControlAmerican Journal of Nephrology, 21
A. Douvdevani, J. Rapoport, A. Konforty, R. Yulzari, A. Moran, C. Chaimovitz (1995)
Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages.Journal of the American Society of Nephrology : JASN, 6 2
S. Davies, J. Bryan, L. Phillips, Russell Gi (1996)
Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 11 3
A. Vriese, Allan Flyvbjerg, S. Mortier, Ronald Tilton, Norbert Lameire (2003)
Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane.Journal of the American Society of Nephrology : JASN, 14 8
J. Bargman, K. Thorpe, D. Churchill (2001)
Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study.Journal of the American Society of Nephrology : JASN, 12 10
G. London, S. Marchais, M. Safar, A. Genest, A. Guérin, F. Métivier, K. Chedid, Alena London (1990)
Aortic and large artery compliance in end-stage renal failure.Kidney international, 37 1
J. Passlick–Deetjen, T. Schaub, H. Schilling (2002)
Solutions for APD: special considerations.Seminars in dialysis, 15 6
P. Dionisio, M. Valenti, R. Bergia, E. Caramello, E. Stramignoni, I. Berto, M. Pellerey, P. Bajardi (1997)
Influence of the hydration state on blood pressure values in a group of patients on regular maintenance hemodialysis.Blood purification, 15 1
C. Konings, J. Kooman, M. Schonck, R. Dammers, E. Cheriex, Andrea Meulemans, A. Hoeks, B. Kreel, U. Gladziwa, F. Sande, K. Leunissen (2002)
Fluid Status, Blood Pressure, and Cardiovascular Abnormalities in Patients on Peritoneal DialysisPeritoneal Dialysis International, 22
N. Topley (1998)
Membrane longevity in peritoneal dialysis: impact of infection and bio-incompatible solutions.Advances in renal replacement therapy, 5 3
M.C. Pinerolo, M. Porri, G. D’Amico (1999)
Recurrent Sterile Peritonitis at Onset of Treatment with Icodextrin SolutionPeritoneal Dialysis International, 19
S. Davies, L. Phillips, Russell Gi (1998)
Peritoneal solute transport predicts survival on CAPD independently of residual renal function.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 13 4
M. Nakayama, Y. Kawaguchi, Kenichi Yamada, T. Hasegawa, K. Takazoe, N. Katoh, H. Hayakawa, N. Osaka, H. Yamamoto, Aiichirou Ogawa, H. Kubo, T. Shigematsu, O. Sakai, S. Horiuchi (1997)
Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD.Kidney international, 51 1
R. Krediet, B. Lindholm, B. Rippe (2000)
Pathophysiology of Peritoneal Membrane FailurePeritoneal Dialysis International, 20
S. Fletcher, G. Stables, J. Turney (1998)
Icodextrin allergy in a peritoneal dialysis patient.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 13 10
C. Basile, F. Padova, A. Montanaro, R. Giordano (2003)
The impact of relapsing sterile icodextrin-associated peritonitis on peritoneal dialysis outcome.Journal of nephrology, 16 3
W. Biesen, R. Vanholder, Norbert Lameire (1998)
Recent developments in osmotic agents for peritoneal dialysis.Advances in renal replacement therapy, 5 3
C. Mistry, C. Mistry, R. Gokal, R. Gokal, E. Peers, E. Peers, C. Brown, Stephen Smith, D. Edwards, B. Junor, A. Gordon, M. Mcmillan, M. Robertson, J. Michael, J. Mckain, M. Raftery, J. Peters, E. Clutterbuck, M. Clemenger, J. Walls, C. Orton, T. Goodship, J. Grieves, J. Olubodun, F. Jackson, D. Dharmasena, G. Hourahane, D. Howarth, R. Boyes, L. Clisby, Y. Beran (1994)
A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.Kidney international, 46 2
A. Imholz, G. Koomen, D. Struijk, L. Arisz, R. Krediet (1994)
Fluid and solute transport in CAPD patients using ultralow sodium dialysate.Kidney international, 46 2
J. Witowski, K. Korybalska, J. Wiśniewska, A. Bręborowicz, G. Gahl, U. Frei, J. Passlick–Deetjen, A. Jörres (2000)
Effect of glucose degradation products on human peritoneal mesothelial cell function.Journal of the American Society of Nephrology : JASN, 11 4
Bengt Rippe, Ole Simonsen, Olle Heimbürger, Anders Christensson, Börje Haraldsson, G. Stelin, Lars Weiss, Finn.-David. Nielsen, Susanne Bro, Michael Friedberg, A. Wieslander (2001)
Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.Kidney international, 59 1
G. Gillerot, O. Devuyst (2003)
Molecular mechanisms modifying the peritoneal membrane exposed to peritoneal dialysis.Clinical nephrology, 60 1
Margje Monquil, A. Imholz, D. Struijk, R. Krediet (1995)
Does Impaired Transcellular Water Transport Contribute to Net Ultrafiltration Failure during CAPD?Peritoneal Dialysis International, 15
K. Michael, Lam Tang, M. Bending, J. Kwan (1997)
Icodextrin Hypersensitivity in a Capd PatientPeritoneal Dialysis International, 17
K. Amann, A. Mandelbaum, U. Schwarz, E. Ritz (1996)
Hypertension and left ventricular hypertrophy in the CAPD patient.Kidney international. Supplement, 56
M. Feriani, J. Kirchgessner, G. Greca, J. Passlick–Deetjen (1998)
Randomized long-term evaluation of bicarbonate-buffered CAPD solution.Kidney international, 54 5
J. Leypoldt, David Charney, Alfred Cheung, Cynthia Naprestek, Bonnie Akin, Ty Shockley (1995)
Ultrafiltration and solute kinetics using low sodium peritoneal dialysate.Kidney international, 48 6
T. Liberek, N. Topley, A. Jörres, M. Petersen, G. Coles, G. Gahl, J. Williams (1993)
Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH.Nephron, 65 2
T. Miyata, K. Horie, Y. Ueda, Y. Fujita, Y. Izuhara, H. Hirano, K. Uchida, A. Saito, C. Strihou, K. Kurokawa (2000)
Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.Kidney international, 58 1
(2002)
Serum imidazo - lone in CAPD patients treated with the new dual - chambered PD fluid Balance
K. Honda, K. Nitta, S. Horita, W. Yumura, H. Nihei, R. Nagai, K. Ikeda, S. Horiuchi (1999)
Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 14 6
M. Koç, A. Toprak, H. Tezcan, A. Bihorac, E. Akoĝlu, I. Ozener (2002)
Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 17 9
K. Ateş, G. Nergizoğlu, K. Keven, A. Sen, S. Kutlay, Ş. Ertürk, N. Duman, O. Karatan, A. Ertug (2001)
Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.Kidney international, 60 2
(1994)
Gokal R: Can ultrafiltration
E. Boulanger, M. Wautier, J. Wautier, B. Boval, Y. Panis, N. Wernert, P. Danzé, P. Dequiedt (2002)
AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.Kidney international, 61 1
A. Schmidt, S. Yan, J. Wautier, David Stern (1999)
Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.Circulation research, 84 5
This paper reviews the most recent clinical data on the volume status of long-term peritoneal dialysis (PD) patients. It appears that many PD patients are volume overloaded, associated with a high prevalence of hypertension and left ventricular hypertrophy. In the presence of the poor results in patients with peritoneal ultrafiltration, the introduction of the polyglucose solution, icodextrin, has ameliorated volume control in some of these patients. In a second part of the review, some of the structural and functional alterations in the peritoneal membrane and the role of glucose degradation products (GDP) in the commonly used dialysates as well as the resulting formation of advanced glycation end products are described. The introduction of low GDP-containing solutions at normal pH has at least in experimental models of PD attenuated the hemodynamic changes observed with the classical solutions. The solutions at normal pH containing either bicarbonate or a mixture of bicarbonate/lactate were clinically associated with less inflow pain.
Blood Purification – Karger
Published: Jul 1, 2004
Keywords: Volume control; Ultrafiltration failure; Biocompatibility; Glucose degradation products; Left ventricular hypertrophy; Peritoneal dialysis
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.